Trade Name Sensipar
Orphan Indication Hypercalcemia in patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo surgery
USA Market Approval USA
USA Designation Date 2010-04-30 00:00:00
Sponsor Amgen, Inc.;One Amgen Center Drive, Bldg 17, 1A-4-4, Mail Stop 17-1-B;Thousand Oaks, California, 91320